Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shexiang Tongxin Dropping Pill for chronic stable coronary artery disease with stable angina
ChiCTR-IPR-15006020Phase 4Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Shexiang Tongxin Dropping Pills in coronary arteriosclerosis and angina pectoris (2 arms), sponsored by Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: Total exercise duration and Metabolic equivalents. Planned start Jul 2014; status: not yet recruiting.
02
Drugs
Shexiang Tongxin Dropping Pills
03
Conditions
coronary arteriosclerosisangina pectoris
Beyond the preview
Go deeper on ChiCTR-IPR-15006020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006020.